Rx Copay Coupons “Discouraged” In Exchange Plans But Not Barred By Anti-Kickback Laws – CMS
This article was originally published in The Pink Sheet Daily
In a recent guidance, CMS wants to discourage exchange plans from allowing third-party patient assistance such as drug copay coupons, even though it affirms a recent statement from HHS Secretary Sebelius that such payments would not violate anti-kickback laws.
You may also be interested in...
If not reversed by the Biden Administration, demo program that puts plans at increased risk in catastrophic phase would also enhance negotiating leverage for drugs in the protected classes.
Tactic aims to allow incoming Administration to scrutinize so-called ‘midnight rules’ issued in the final days of the Trump Administration before they take effect. Regulators may also solicit stakeholder comments on delayed rules.
The tactic aims to allow the new Biden administration to scrutinize so-called “midnight rules” issued in the final days of the Trump administration before they take effect. One reg targeted by the freeze is the recent SUNSET rule from the US HHS, which would require the department and its agencies – including the FDA – to review all regulations every 10 years to determine whether they’re still necessary.